SIBO proves difficult to treat due to high recurrence rates (30-60% within 9-12 months), even after antibiotics, because diets alone fail to eradicate bacterial overgrowth and don't address root causes like impaired gut motility.
Main Challenges
Antibiotics like rifaximin clear overgrowth initially (60-70% success) but bacteria recolonize without fixing underlying issues: migrating motor complex (MMC) dysfunction from food poisoning or stress, structural problems (e.g., adhesions from surgery), low stomach acid from PPIs, or immune deficits. Healthiest diets (low-FODMAP, SCD) starve bacteria temporarily but can't fully eliminate them or restore motility, leading to relapse.
Not a New Phenomenon
SIBO isn't modern—it's ancient, linked to gut dysbiosis from infections or surgeries, with humans biologically adapted via MMC sweeps; today's antibiotics target it effectively short-term, but long-term success demands prokinetics, root cause therapy, and sometimes ongoing low-dose antimicrobials. Diet optimizes but rarely suffices solo.
0 comments